the lobulated contour of the liver is detected at preoperative imaging studies or when the coarsely lobated liver is encountered during surgery for carcinoma of the rectum.
Introduction
Hepar lobatum refers to liver deformity, including an irregular, lobulated contour with crevices and linear depressions, seen in patients with tertiary syphilis, resulting from healing gummas and scar contraction [1, 2] . Many cases with the classic appearance of hepar lobatum have been described [3] [4] [5] [6] [7] , especially in association with metastatic breast carcinoma. Recently, we encountered a liver dysmorphy not related to syphilis in a patient with metastatic rectal carcinoma.
Clinical Presentation and Intervention
A 50-year-old man presented with a 2-year history of bleeding per anum, tenesmus, malaise and weakness. The patient had experienced increasing constipation and a sense of obstruction in the rectum for 3 months. His medical history showed that the patient had undergone an open hemorrhoidectomy and a hydroce-
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On admission, physical examination was normal, but hematological examination showed a hemoglobin count of 11.0 g/dl (normal: 13.6-17.2 g/dl) and a hematocrit of 33.4% (normal: 39.5-50.3%). The level of carcinoembryonic antigen was 48.9 ng/ml (normal range: 0-4.3 ng/ml). Preoperative syphilis serum tests, including venereal disease research laboratory test, treponema pallidum hemagglutination assay and fluorescent treponemal antibody absorption test were negative. Colonoscopy revealed a large, fragile polypoid lesion extending from the anal canal to the rectum. Biopsy results showed rectal adenocarcinoma. Abdominal computed tomography (CT) showed lobar enlargement and a lobulated contour, mainly in the left lobe of the liver ( fig. 1 ). The portal and hepatic veins were patent. No primary or metastatic lesions were detected in the liver. The patient received preoperative chemoradiotherapy. Radiotherapy consisted of a total of 4,500 cGy delivered in 28 fractions of 180 cGy 5 times weekly to the pelvis. During the first and fifth weeks of radiotherapy, 5-fluorouracil (5-FU) was given as a 120-hour continuous infusion at a dose of 225 mg/m 2 per day. A formal abdominoperineal resection of the rectum was performed 6 weeks after the completion of neoadjuvant chemoradiotherapy. On exploration of the abdomen, the liver manifested the gross appearance of hepar lobatum. The surface was coarsely lobated (the so-called 'potato liver') ( fig. 2 ) , and the capsule was slightly thickened. The surface of the lobulated areas was smooth. More nodular masses were concentrated on the anterior margins of segments III and IV A of the liver. A lesion measuring 1 ! 1 cm, on the surface of segment V of the liver, was excised locally, and the specimen was sent for frozen section examination. The result was reported to be liver metastasis from adenocarcinoma.
Histological examination of the liver biopsy showed a necrotic tumor growth in subcapsular localization of the liver ( fig. 3 a) . There were scattered foci of dilatation of portal veins and sinusoids ( fig. 3 b) . There were no granulomas, giant cells or features indicating coexisting chronic hepatitis. The Ziehl-Neelsen stain for acid-fast organisms, the periodic acid-Schiff and Grocott methenamine silver stains for fungal and protozoal infections were negative. Schistosome ova were not present in noncancerous areas of the liver tissue. Histopathological examination of the APR specimen revealed moderately differentiated rectal adenocarci- 
Discussion
Hepar lobatum is a classic morphological entity that has been used synonymously with tertiary syphilitic liver because of its characteristic morbid anatomy at autopsy [2, 8] . Hepar lobatum carcinomatosum (HLC) is the rarest form of metastatic liver disease. Busni [9] first introduced the term 'hepar lobatum carcinomatosum' in 1924. HLC is characterized by the combination of multifocal cancer-bearing scars and compensatory hyperplasia of the spared liver parenchyma. HLC may resemble its syphilitic counterpart, but tumor tissue can be demonstrated around or independently of those scar-like areas. Both scirrhous stromal reaction to carcinoma and vascular impairment due to infiltration have been suggested for the pathogenesis of multifocal cancer-bearing scars [10] . Metastatic liver cancers from the stomach, gallbladder, pancreas, etc. may commonly be associated with a scirrhous stroma, but HLC has not been routinely observed with such primaries.
The pathogenetic mechanism of HLC may be similar to that of hepar lobatum syphiliticum. In this respect, 2 further conditions may be required: inhomogeneous or diffuse but multifocal distribution of the affected blood vessels and slow progression of the process allowing the spared liver parenchyma to develop compensatory hypertrophy. Blockage of portal venous branches may cause Zahn's infarcts. Occlusion of hepatic venous branches may have a congestive effect, leading to its gradual shrinkage with fibrosis. Obstruction of the lymphatic vessels may add a dystrophic effect in terms of lymph stasis [10] . Gravel et al. [11] reported that, in their 2 cases of HLC associated with metastatic breast carcinoma, minute tumor deposits were seen mainly within sinusoidal spaces or within portal tracts along the junction with parenchyma. Occasional venules and/or lymphatics within fibrous septa contained intraluminal tumor cell clusters. However, we did not observe such changes in this case. In our patient, the only striking microscopic finding was focal areas of dilatation of portal veins and sinusoids which did not show any occlusion by tumor emboli. Moreover, triphasic helical CT of the liver revealed the portal and hepatic veins to be patent and no intrahepatic intravascular tumor thromboses or metastatic lesions were detected.
Hepar lobatum resulting from metastatic carcinoma is a very rare phenomenon, mostly documented in the setting of multiagent chemotherapy-treated breast carcinoma. Chin et al. [7] reported an unusual etiology for hepar lobatum which was related to the administration of chemotherapeutic agents (5-FU, adriamycin and mitomycin) resulting in the destruction of the tumor cells with consequent fissuring cicatrization in a patient who had gastric carcinoma with metastasis to the liver. In our case, however, the dose of 5-FU, the neoadjuvant chemotherapeutic agent used, was within the ordinary range, and repeated CT examinations prior to and after their administration demonstrated no alteration in liver morphology. Many chemotherapeutic agents, including alkylating agents (cyclophosphamide), antimetabolites (methotrexate, 5-FU), cytotoxic antibiotics (doxorubicin, epirubicin, mitomycin, mitoxanthrone) and plant alkaloids (vinblastine, paclitaxel, docetaxel) have been used in patients reported to have developed HLC. Of these, no common denominator single agent was used in the treatment of patients who developed hepar lobatum. Except for methotrexate, none of the antineoplastic agents are known to induce significant hepatic fibrosis. Methotrexate can induce portal arachnoid fibrosis and sinusoidal collagen deposition occasionally leading to micronodular cirrhosis [12] . However, this patient with hepar lobatum who had received 5-FU in the neoadjuvant setting had no such pattern of fibrosis.
Conclusion
We described a case of liver dysmorphy revealed by metastatic rectal carcinoma. The liver morphology was misleading, mimicking tertiary syphilitic liver. When it is difficult to identify the cause of liver dysmorphy in a patient with known colorectal cancer, hepar lobatum carcinomatosum should be considered in the differential diagnosis.
